Quarterly ResultMay 5, 2026, 07:06 AM
Sotera Health Q1 Revenue +10% to $280M; Net Income $27M
AI Summary
Sotera Health reported a strong start to 2026 with Q1 net revenues increasing 10.0% to $280 million and net income reaching $27 million, a significant improvement from a net loss in Q1 2025. Adjusted EPS rose 29% to $0.18, and Adjusted EBITDA increased 10.5%. The company reaffirmed its full-year 2026 financial outlook, and separately announced a planned CEO transition.
Key Highlights
- Q1 2026 net revenues increased 10.0% to $280.045 million (6.5% constant currency).
- Q1 2026 net income was $27 million, compared to a net loss of $13 million in Q1 2025.
- Q1 2026 Adjusted EPS increased 29% to $0.18 per diluted share.
- Q1 2026 Adjusted EBITDA increased 10.5% (6.9% constant currency).
- Sterigenics segment revenue grew 6.1% constant currency to $186 million.
- Nordion segment revenue grew 25.8% constant currency to $42 million.
- Company reaffirmed full-year 2026 outlook for 5.0%-6.5% constant currency net revenues growth.
- Company announced planned CEO transition in a separate release today.